About
A clear pane over a public record
GlassScript helps you read a federal transparency database: the payments that drug and device companies report making to doctors and other clinicians.
What GlassScript is
Type in a doctor's name or a medication, and see what companies have reported paying: meals at educational events, consulting and speaking fees, travel, royalties, research funding. Next to every figure we show context: how it compares with other providers in the same specialty, in the same state, and across the country.
We do not add allegations, ratings, or scores. We add arithmetic, comparison, and plain explanations of what the categories mean.
Where the data comes from
In 2010, Congress passed the Physician Payments Sunshine Act. It requires drug and device makers to report nearly every transfer of value they make to physicians and, in recent years, to physician assistants and nurse practitioners as well. The Centers for Medicare & Medicaid Services (CMS) has published those reports since 2014 in a public database called Open Payments.
The law's premise is simple: financial relationships between industry and medicine should be visible. GlassScript's current copy covers program years 2019-2025 and was published by CMS on June 30, 2026.
Independent by design
GlassScript is an independent project. We are not affiliated with CMS or any government agency, and we take no money from drug or device makers. Figures are shown exactly as reported to CMS by the paying companies. Where we compute something ourselves (totals, medians, percentiles), the method is documented on how we compute things.
Why the framing stays calm
A dollar figure with no context invites the wrong conclusion. Industry payments are legal, and most are routine: a sandwich at a lunch talk, a consulting fee for input on a device design, funding tied to a clinical trial. A payment is not evidence that a doctor did anything wrong, and studies linking payments to prescribing describe patterns across populations, not verdicts about individuals.
So every page that shows money also explains what the number means and what it does not. Transparency works best when it informs rather than alarms.
Who this is for
- Patients and families who want to understand a clinician's industry relationships.
- Journalists and researchers who need clean, contextualized access to Open Payments data.
- Clinicians reviewing their own public record. If that's you, we wrote a page for you.
Questions we hear often are answered on the common questions page.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026).